Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
August 04, 2023 13:05 ET
|
Oxurion NV
Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 12 convertible bonds in Oxurion resulting in a EUR 300,000 capital increase. This is part of Atlas Special...
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
August 04, 2023 13:00 ET
|
Oxurion NV
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 4, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care...
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
July 26, 2023 14:00 ET
|
Oxurion NV
Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special...
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LL
July 26, 2023 13:00 ET
|
Oxurion NV
Regulated Information Leuven, BELGIUM, Boston, MA, US – July 26, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care...
Oxurion Receives Upfront Payment of $400,000 Following Oncurious Asset License by VIB
July 25, 2023 02:00 ET
|
Oxurion NV
Total Potential Development and Commercial Milestones of $32M plus Royalties Leuven, BELGIUM, Boston, MA, US – July 25, 2023 – 8:00 am CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical...
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
July 14, 2023 13:00 ET
|
Oxurion NV
Regulated Information Leuven, BELGIUM, Boston, MA, US – July 14, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care...
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
July 06, 2023 13:05 ET
|
Oxurion NV
Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special...
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
July 06, 2023 13:00 ET
|
Oxurion NV
Regulated Information Leuven, BELGIUM, Boston, MA, US – July 6, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care...
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
July 05, 2023 13:00 ET
|
Oxurion NV
Regulated Information Leuven, BELGIUM, Boston, MA, US – July 5, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care...
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
July 03, 2023 02:00 ET
|
Oxurion NV
Regulated Information Leuven, BELGIUM, Boston, MA, US – July 3, 2023 – 8.00 AM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care...